Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2022-03-21

FDA Approved: LOPINAVIR AND RITONAVIR — Original Application (Laurus Labs Limited)

View source ↗

Summary

FDA approved an original application for a generic fixed-dose combination of lopinavir and ritonavir for HIV-1 infection, manufactured by Laurus Labs Limited.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Lopinavir and Ritonavir (lopinavir/ritonavir)

Snippet

ORIG AP for LOPINAVIR AND RITONAVIR (LOPINAVIR AND RITONAVIR)